Similar Articles
211 Intratumoural microorganism can affect the progression of hepatocellular carcinoma
212 Clinical significance of upregulated Rho GTPase activating protein 12 causing resistance to tyrosine kinase inhibitors in hepatocellular carcinoma
213 Impact of baseline body mass index on the long-term prognosis of advanced hepatocellular carcinoma treated with immunotherapy
214 Conversion therapy for hepatocellular carcinoma to improve treatment strategies for intermediate and advanced stages
215 Liver transplantation following two conversions in a patient with huge hepatocellular carcinoma and portal vein invasion: A case report
216 Advancing prognostic understanding in hepatocellular carcinoma through the integration of genomic instability and lncRNA signatures: GILncSig model
217 Transjugular intrahepatic portosystemic shunt for esophagogastric variceal bleeding in patients with hepatocellular carcinoma and portal vein tumor thrombus
218 Combined transarterial chemoembolization and tislelizumab for patients with unresectable hepatocellular carcinoma
219 Analysis of alkaline phosphatase and γ-glutamyltransferase after radiofrequency ablation of primary liver cancer: A retrospective study
220 Efficacy and safety of B-ultrasound-guided radiofrequency ablation in the treatment of primary liver cancer: Systematic review and meta-analysis
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA